The Asia Pacific irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 739.70 million by 2028 from US$ 448.31 million in 2020; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome and associated conditions and advancements in diagnostics of syndrome. On the other hand, challenges in diagnosis of IBS are likely to restraint the growth of market during the forecast years.
Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. People across the world are witnessing considerable incidence of irritable bowel syndrome. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. According to IBS Global Impact Report, in 2016, estimated prevalence of irritable bowel syndrome in Asia was 9.6%. Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period. To cope up against irritable bowel syndrome, the companies involved in the drug development for irritable bowel syndrome are taking constructive steps to create awareness programs with an aim to spread awareness amongst the population. Such initiatives are anticipated to drive the growth of the irritable bowel syndrome (IBS) diagnostics market. Also, increasing number of FDA approvals and diagnostics development activities are likely to accelerate the growth of the irritable bowel syndrome (IBS) diagnostics market during the forecast period.
With the spread of the COVID-19 pandemic, it is discovered that a significant number of people across the world are suffering from irritable bowel syndrome (IBS), as COVID-19 pandemic has affected the psychological health of people, resulting in a higher level of stress. Stress can exaggerate the symptoms of irritable bowel syndrome (IBS). Thus, the impact of COVID-19 is so far considered positive on the market. Therefore, the growing demand for irritable bowel syndrome (IBS) diagnostics in Asia Pacific is likely to boost the growth of the irritable bowel syndrome (IBS) diagnostics market.
Based on the diagnosis, the Asia Pacific irritable bowel syndrome (IBS) diagnostics market was segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held a larger share of the market and is expected to grow at a faster rate during the coming years.
Based on indication, the Asia Pacific irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation & diarrhea. The pain and cramping segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the Asia Pacific irritable bowel syndrome (IBS) diagnostics market are International Foundation for Gastrointestinal Disorders (IFFGD), National Health Service (NHS) and Centers for Disease Control and Prevention (CDC).
Reasons to Buy
With the spread of the COVID-19 pandemic, it is discovered that a significant number of people across the world are suffering from irritable bowel syndrome (IBS), as COVID-19 pandemic has affected the psychological health of people, resulting in a higher level of stress. Stress can exaggerate the symptoms of irritable bowel syndrome (IBS). Thus, the impact of COVID-19 is so far considered positive on the market. Therefore, the growing demand for irritable bowel syndrome (IBS) diagnostics in Asia Pacific is likely to boost the growth of the irritable bowel syndrome (IBS) diagnostics market.
Based on the diagnosis, the Asia Pacific irritable bowel syndrome (IBS) diagnostics market was segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held a larger share of the market and is expected to grow at a faster rate during the coming years.
Based on indication, the Asia Pacific irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation & diarrhea. The pain and cramping segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the Asia Pacific irritable bowel syndrome (IBS) diagnostics market are International Foundation for Gastrointestinal Disorders (IFFGD), National Health Service (NHS) and Centers for Disease Control and Prevention (CDC).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific irritable bowel syndrome (ibs) diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific irritable bowel syndrome (ibs) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market - By Diagnosis
1.3.2 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market - By Indication
1.3.3 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market- By Country
2. Irritable Bowel Syndrome (IBS) Diagnostics Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC PEST Analysis
4.3 Expert Opinion
5. Irritable Bowel Syndrome (IBS) Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
5.1.2 Increasing Number of FDA Approvals and Diagnostics Developments
5.2 Market Restraint
5.2.1 Challenges in Diagnosis of IBS
5.3 Market Opportunity
5.3.1 Increasing Disposable Incomes of the Population
5.4 Future Trend
5.4.1 Development of Medical Devices for the Diagnosis of Irritable Bowel Syndrome
5.5 Impact analysis
6. Irritable Bowel Syndrome (IBS) Diagnostics Market- Asia Pacific Analysis
6.1 Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis
7. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis- by Diagnosis
7.1 Overview
7.2 Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Lactose Intolerance Tests
7.3.3.1 Overview
7.3.3.2 Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Breath Test for Bacterial Overgrowth
7.3.4.1 Overview
7.3.4.2 Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool Tests
7.3.5.1 Overview
7.3.5.2 Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Blood Tests
7.3.6.1 Overview
7.3.6.2 Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 CT-Scan or X-ray
7.4.3.1 Overview
7.4.3.2 CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Upper Endoscopy
7.4.4.1 Overview
7.4.4.2 Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Colonoscopy
7.4.5.1 Overview
7.4.5.2 Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis - By Indication
8.1 Overview
8.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
8.3 Pain and Cramping
8.3.1 Overview
8.3.2 Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diarrhea
8.4.1 Overview
8.4.2 Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Constipation
8.5.1 Overview
8.5.2 Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Alternating Constipation & Diarrhea
8.6.1 Overview
8.6.2 Alternating Constipation & Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
9. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 -Asia Pacific Analysis
9.1 Asia Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.1.1 Overview
9.1.2 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.1.3 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.3.1 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.3.2 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.3.2.1 China: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.3.2.2 China: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.1.3.3 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.1.4 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.4.1 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.4.2 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.4.2.1 Japan: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.4.2.2 Japan: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.1.4.3 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.1.5 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.5.2.1 India: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.5.2.2 India: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.1.5.3 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.1.6 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.6.1 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.6.2 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.6.2.1 Australia: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.6.2.2 Australia: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.1.6.3 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.1.7 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.7.1 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.7.2 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.7.2.1 South Korea: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.7.2.2 South Korea: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.1.7.3 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.1.8 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.1.8.2.1 Rest of Asia-Pacific: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.1.8.2.2 Rest of Asia-Pacific: Imaging Tests Market, by Type, by Imaging Tests, 2019-2028 (USD Million)
9.1.8.3 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
10. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Diagnostics Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Irritable Bowel Syndrome (IBS) Diagnostics Market- Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Commonwealth Diagnostics International
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Genova Diagnostics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Prometheus Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Inova Diagnostics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Biohit Oyj
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Aerodiagnostics, LLC.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
LIST OF TABLES
Table 1. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 2. China: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 3. China: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 4. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 9. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 10. India: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 11. India: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 12. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia-Pacific: Laboratory Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia-Pacific: Imaging Tests Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation
Figure 2. Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Region
Figure 3. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Overview
Figure 4. Laboratory Tests Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 5. Pain and Cramping Held Largest Share of Indication Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 6. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market - Leading Country Markets (US$ Million)
Figure 7. APAC: PEST Analysis
Figure 8. Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
Figure 11. Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
Figure 21. Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Alternating Constipation & Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 26. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 27. China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Asia Pacific Countries
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Genova Diagnostics
- Commonwealth Diagnostics International
- Prometheus Laboratories
- Inova Diagnostics, Inc.
- Biohit Oyj
- Aerodiagnostics, LLC
Table Information
| Report Attribute | Details |
|---|---|
| Published | May 2021 |
| Forecast Period | 2020 - 2028 |
| Estimated Market Value ( USD | $ 448.31 Million |
| Forecasted Market Value ( USD | $ 739.7 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Asia Pacific |
